147 related articles for article (PubMed ID: 2065939)
1. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
Creutzig U; Ritter I; Schellong G
Gematol Transfuziol; 1991 Jan; 36(1):16-21. PubMed ID: 2065939
[No Abstract] [Full Text] [Related]
2. The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
Creutzig U; Ritter J; Riehm H; Budde M; Schellong G
Haematol Blood Transfus; 1987; 30():71-5. PubMed ID: 3305225
[No Abstract] [Full Text] [Related]
3. Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83.
Ritter J; Creutzig U; Schellong G
Haematol Blood Transfus; 1990; 33():185-92. PubMed ID: 2182410
[No Abstract] [Full Text] [Related]
4. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
[TBL] [Abstract][Full Text] [Related]
5. Improved treatment results in childhood acute nonlymphoblastic leukemia with the BFM-AML protocol 78 in a multicenter study in the GDR.
Hermann J; Plenert W; Zintl F; Fuchs D; Malke H; Dörffel W; Eggers G; Exadaktylos P; Hilgenfeld E; Kotte W
Haematol Blood Transfus; 1987; 30():76-82. PubMed ID: 3305226
[TBL] [Abstract][Full Text] [Related]
6. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia.
Rees JK; Gray R; Hayhoe FG
Haematol Blood Transfus; 1987; 30():35-7. PubMed ID: 2442075
[No Abstract] [Full Text] [Related]
7. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
Rees JK; Gray RG
Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
[No Abstract] [Full Text] [Related]
8. Treatment of childhood acute nonlymphocytic leukemia: cooperative Austrian-Hungarian study AML-IGCI-84.
Fink FM; Gadner H; Grümayer ER; Kardos G; Revesz T; Urban C; Mutz I; Ausserer B; Schuler D
Haematol Blood Transfus; 1990; 33():233-6. PubMed ID: 2182415
[No Abstract] [Full Text] [Related]
9. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
10. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
Ochocka M; Zelenay E
Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
[No Abstract] [Full Text] [Related]
11. Treatment of acute lymphoblastic leukemia in children with the BFM protocol: a cooperative study and analysis of prognostic factors.
Maurus R; Boilletot A; Otten J; Philippe N; Benoit Y; Behar C; Casteels-Van Daele M; Chantraine JM; Delbeke MJ; Gyselinck J
Haematol Blood Transfus; 1987; 30():466-70. PubMed ID: 3305214
[No Abstract] [Full Text] [Related]
12. [Results of the treatment of lymphoblastic leukemia by the BFM program in children--a 5-year observation].
Rokicka-Milewska R; Derulska D; Makowska K; Skwarska E; Lewicki Z
Acta Haematol Pol; 1987; 18(1-2):1-8. PubMed ID: 3481150
[No Abstract] [Full Text] [Related]
13. Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors.
Weinstein H; Grier H; Gelber R; Camitta B; Link M; Delorey M; Price K
Haematol Blood Transfus; 1987; 30():88-92. PubMed ID: 3476388
[No Abstract] [Full Text] [Related]
14. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
[No Abstract] [Full Text] [Related]
15. [Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group].
Creutzig U; Ritter J; Heyen P; Berthold F; Henze G; Kabisch H; Lampert F; Niethammer D; Riehm H; Schellong G
Klin Padiatr; 1992; 204(4):236-45. PubMed ID: 1518259
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report.
Lampkin BC; Woods WG; Buckley JD; Hammond GD
Haematol Blood Transfus; 1990; 33():210-4. PubMed ID: 1691130
[No Abstract] [Full Text] [Related]
18. Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.
Büchner T; Hiddemann W; Blasius S; Koch P; Maschmeyer G; Tirier C; Sodomann H; Kuse R; Thiel E; Ludwig WD
Haematol Blood Transfus; 1990; 33():261-6. PubMed ID: 2182419
[No Abstract] [Full Text] [Related]
19. [Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987].
Freigeiro D; Scaglione C; Santarelli MT; Sackmann Muriel F; Jiménez E; Pavlovsky S; Bustelo P; Richard L; Kohan R; Kvicala R
Sangre (Barc); 1989 Jun; 34(3):221-8. PubMed ID: 2669186
[TBL] [Abstract][Full Text] [Related]
20. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
[No Abstract] [Full Text] [Related]
[Next] [New Search]
